William T. Muse
Edgewood Chemical Biological Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by William T. Muse.
Cutaneous and Ocular Toxicology | 2008
Paul A. Dabisch; Michael S. Horsmon; James T. Taylor; William T. Muse; Dennis B. Miller; Douglas R. Sommerville; Robert J. Mioduszewski; Sandra A. Thomson
The present study was undertaken to investigate the miotic potency of soman vapor in the rat, as well as gender differences in the miotic response to soman vapor that have been reported previously for other nerve agents. The results of the present study demonstrate that the miotic potency of soman vapor is significantly less than that of other nerve agents, and that female rats are 2.5–3.0 times more sensitive to soman vapor than male rats. The results also demonstrate that ocular acetylcholinesterase and butyrylcholinesterase activities differ between males and females, although this difference is not likely large enough to account for the observed gender difference.
Inhalation Toxicology | 2006
William T. Muse; Sandra A. Thomson; Charles L. Crouse; Kathy L. Matson
This study tested and optimized various methodologies to generate, sample, and characterize GB and GF test atmospheres in an inhalation chamber, particularly at low vapor levels. A syringe drive/spray atomization system produced vapor concentrations at a range of 1–50 mg/m3. A saturator cell was used to generate vapor at sub-lethal concentrations ranging from 1 mg/m3 down to low levels approaching the threshold limit value time-weighted average (TLV-TWA) of 0.0001 mg/m3 for GB. Both generation techniques demonstrated the ability to produce stable vapor concentrations over extended exposure periods. This capability was important to determine sublethal nerve agent effects, such as miosis, for inhalation toxicology studies. In addition, the techniques employed for producing and maintaining low-level agent vapor would lay the foundation for testing less volatile chemical warfare agents such as VX.
Drug and Chemical Toxicology | 1997
William T. Muse; Jeffrey D. Bergmann; David C. Burnett; Charles L. Crouse; Bernardita P. Gaviola; Sandra A. Thomson
The terephthalic acid (TPA) smoke obscurants (M-83 grenade and M-8 smoke pot) were developed by the U.S. Army for training purposes to replace the more toxic hexachloroethane (HC) smoke. Inhalation toxicity testing and chemical characterization of pyrotechnically generated TPA was conducted to assess the health hazard potential of TPA and its combustion products. Fisher 344 rats were subjected to acute and repeated exposures to TPA smoke generated from the M-83 grenade. Acute exposure levels ranged from 150-1,900 mg/m3 for 30 minutes and repeated dose exposures ranged from 128-1,965 mg/m3 for 30 min/day for 5 days. Exposed and control rats were evaluated for toxic signs, and histopathologic changes. During exposure, the rats exhibited slight to moderate lacrimation, rhinorrhea, lethargy and dyspnea, which reversed within 1-hr post-exposure. No deaths occurred, even at the highest smoke concentrations. Histopathological changes were confined to exposure related nasal necrosis and inflammation in both the acute and repeated dose exposures at levels above 900 mg/m3. Chemical characterization of the M-83 grenade and the M-8 smoke pot showed that formaldehyde, benzene and carbon monoxide were the major organic vapor by-products formed. These by-products were above their respective ACGIH threshold limit values at various concentrations, but should not pose a hazard if the smoke is deployed in an open area. Overall, TPA is a safer training smoke to replace the HC smoke.
Inhalation Toxicology | 2014
Stanley W. Hulet; Douglas R. Sommerville; Dennis B. Miller; Jacqueline A. Scotto; William T. Muse; David C. Burnett
Abstract Sexually mature male and female Gottingen minipigs were exposed to various concentrations of GB and GF vapor via whole-body inhalation exposures or to liquid GB or GF via intravenous or subcutaneous injections. Vapor inhalation exposures were for 10, 60 or 180 min. Maximum likelihood estimation was used to calculate the median effect levels for severe effects (ECT50 and ED50) and lethality (LCT50 and LD50). Ordinal regression was used to model the concentration × time profile of the agent toxicity. Contrary to that predicted by Haber’s rule, LCT50 values increased as the duration of the exposures increased for both nerve agents. The toxic load exponents (n) were calculated to be 1.38 and 1.28 for GB and GF vapor exposures, respectively. LCT50 values for 10-, 60- and 180-min exposures to vapor GB in male minipigs were 73, 106 and 182 mg min/m3, respectively. LCT50 values for 10-, 60 - and 180-min exposures to vapor GB in female minipigs were 87, 127 and 174 mg min/m3, respectively. LCT50 values for 10-, 60- and 180-min exposures to vapor GF in male minipigs were 218, 287 and 403 mg min/m3, respectively. LCT50 values for 10-, 60- and 180-min exposures in female minipigs were 183, 282 and 365 mg min/m3, respectively. For GB vapor exposures, there was a tenuous gender difference which did not exist for vapor GF exposures. Surprisingly, GF was 2–3 times less potent than GB via the inhalation route of exposure regardless of exposure duration. Additionally GF was found to be less potent than GB by intravenous and subcutaneous routes.
Drug and Chemical Toxicology | 2017
Linnzi K.M. Wright; Lucille A. Lumley; Robyn B. Lee; James T. Taylor; Dennis B. Miller; William T. Muse; Edward J. Emm; Christopher E. Whalley
Abstract Chemical warfare nerve agents (CWNA) inhibit acetylcholinesterase and are among the most lethal chemicals known to man. Children are predicted to be vulnerable to CWNA exposure because of their smaller body masses, higher ventilation rates and immature central nervous systems. While a handful of studies on the effects of CWNA in younger animals have been published, exposure routes relevant to battlefield or terrorist situations (i.e. inhalation for sarin) were not used. Thus, we estimated the 24 h LC50 for whole-body (10 and 60 min) exposure to sarin using a stagewise, adaptive dose design. Specifically, male and female Sprague-Dawley rats were exposed to a range of sarin concentrations (6.2–44.0 or 1.6–12.5 mg/m³) for either 10 or 60 min, respectively, at six different times during their development (postnatal day [PND] 7, 14, 21, 28, 42 and 70). For male and female rats, the lowest LC50 values were observed for PND 14 and the highest LC50 values for PND 28. Sex differences were observed only for PND 42 for the 10 min exposures and PND 21 and 70 for the 60 min exposures. Thus, younger rats (PND 14) were more susceptible than older rats (PND 70) to the lethal effects of whole-body exposure to sarin, while adolescent (PND 28) rats were the least susceptible and sex differences were minimal. These results underscore the importance of controlling for the age of the animal in research on the toxic effects associated with CWNA exposure.
Toxicological Sciences | 2002
Robert J. Mioduszewski; J. Manthei; R. Way; D. Burnett; B. Gaviola; William T. Muse; Sandra A. Thomson; Douglas R. Sommerville; R. Crosier
Journal of Analytical Toxicology | 2004
Edward M. Jakubowski; Jeffrey M. McGuire; Ronald A. Evans; J.L. Edwards; Stanley W. Hulet; B.J. Benton; J.S. Forster; D.C. Burnett; William T. Muse; Kathy L. Matson; C.L. Crouse; Robert J. Mioduszewski; Sandra A. Thomson
Journal of Analytical Toxicology | 2008
Ronald A. Evans; Edward M. Jakubowski; William T. Muse; Kathy L. Matson; Stanley W. Hulet; Robert J. Mioduszewski; Sandra A. Thomson; A.L. Totura; Julie A. Renner; C.L. Crouse
Journal of Ocular Pharmacology and Therapeutics | 2005
Paul A. Dabisch; David C. Burnett; Dennis B. Miller; Edward M. Jakubowski; William T. Muse; Jeffry S. Forster; Jacqueline A. Scotto; Jill R. Jarvis; Emily A. Davis; Stanley W. Hulet; Sharon A. Reutter; Robert J. Mioduszewski; Sandra A. Thomson
Toxicological Sciences | 2007
Paul A. Dabisch; Michael S. Horsmon; William T. Muse; Robert J. Mioduszewski; Sandra A. Thomson